Frontier Capital Management CO LLC Acadia Pharmaceuticals Inc Transaction History

Frontier Capital Management CO LLC

$9.96 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $1.37 Million - $2.1 Million	65,973 Added 8.71%	823,586 $25.8 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $2.25 Million - $3.61 Million	107,903 Added 16.61%	757,613 $15.8 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $2.06 Million - $2.97 Million	115,655 Added 21.66%	649,710 $15.6 Million
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $2.83 Million - $3.62 Million	173,178 Added 47.99%	534,055 $10.1 Million
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $1.76 Million - $2.3 Million	-123,686 Reduced 25.53%	360,877 $5.75 Million
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $1.15 Million - $1.49 Million	-81,760 Reduced 14.44%	484,563 $7.93 Million
Q2 2022 Jul 20, 2022	SELL	$13.01 - $27.22 $4.07 Million - $8.51 Million	-312,667 Reduced 35.57%	566,323 $7.98 Million
Q1 2022 Apr 14, 2022	SELL	$20.94 - $27.5 $3.72 Million - $4.89 Million	-177,723 Reduced 16.82%	878,990 $21.3 Million
Q4 2021 Jan 19, 2022	BUY	$16.79 - $27.09 $11.2 Million - $18.1 Million	667,144 Added 171.25%	1,056,713 $24.7 Million
Q3 2021 Oct 19, 2021	SELL	$15.78 - $24.77 $10.4 Million - $16.3 Million	-657,778 Reduced 62.8%	389,569 $6.47 Million
Q2 2021 Aug 09, 2021	BUY	$19.4 - $27.42 $11.4 Million - $16.1 Million	585,970 Added 127.0%	1,047,347 $25.5 Million
Q1 2021 May 13, 2021	SELL	$25.02 - $54.99 $12.4 Million - $27.3 Million	-497,315 Reduced 51.87%	461,377 $11.9 Million
Q4 2020 Jan 19, 2021	SELL	$41.04 - $56.79 $1.45 Million - $2.01 Million	-35,347 Reduced 3.56%	958,692 $51.3 Million
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $7.01 Million - $11 Million	-192,445 Reduced 16.22%	994,039 $41 Million
Q2 2020 Jul 17, 2020	SELL	$39.26 - $52.73 $6.63 Million - $8.91 Million	-168,971 Reduced 12.47%	1,186,484 $57.5 Million
Q1 2020 Apr 16, 2020	BUY	$31.65 - $46.87 $42.9 Million - $63.5 Million	1,355,455 New	1,355,455 $57.3 Million
Q2 2018 Aug 03, 2018	SELL	$15.07 - $22.34 $4.36 Million - $6.47 Million	-289,443 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$22.47 - $32.33 $4.53 Million - $6.52 Million	201,709 Added 229.91%	289,443 $6.5 Million
Q4 2017 Jan 18, 2018	SELL	$26.84 - $39.14 $8.56 Million - $12.5 Million	-318,787 Reduced 78.42%	87,734 $2.64 Million
Q3 2017 Oct 31, 2017	BUY	$29.49 - $38.37 $12 Million - $15.6 Million	406,521	406,521 $15.3 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Account